West to Feature Innovations in Injectable Drug Packaging and Delivery during CPhI InnoPack Worldwide 2016
September 20, 2016 – Pharmaceutical –
Exton, Pa ó September 20, 2016 (Booth #2M22) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it will present a continuous improvement approach to address steadily increasing patient and quality expectations at CPhI InnoPack Worldwide 2016. From 4-6 October in Barcelona, Spain, West will also showcase high-quality packaging components and drug delivery solutions at booth #2M22.
‘As sophisticated biologic drug products are becoming more prevalent for the treatment of chronic conditions, it is imperative that integrated containment and delivery systems are designed to accommodate these highly sensitive molecules,’ said Mike Schaefers, Vice President, Global Product Management and Marketing Operations at West. ‘At CPhI InnoPack Worldwide, we look forward to sharing the technologically advanced packaging and delivery solutions West has to offer our pharmaceutical and biopharmaceutical partners in this new era of sensitive biologics.’
At CPhI InnoPack Worldwide, West will present the following educational session:
- 5 October, 11am – ‘Lifecycle management and continuous improvement efforts on components to address steadily increasing patient and quality expectations,’ Christa Jansen-Otten, Director, Product Management, Prefillable Solutions & Delivery at West
Additionally, during the three-day meeting, West will showcase several innovative drug delivery system and packaging component technologies, including:
- 1-3mL NovaPure plungers – High-quality components for higher-volume pre-filled delivery systems, designed using Quality by Design (QbD) principles to reduce particulate and ensure consistency of delivery
- SmartDose technology platform – Recently, Amgen announced FDA approval for a single, monthly 420 mg dose delivery option for Repatha (evolocumab), utilizing the SmartDose technology. This is the first combination product that incorporates SmartDose technology for use in the United States
- Daikyo Crystal Zenith vials and 1mL long insert needle syringes – Technologically advanced containment systems manufactured from a cyclic olefin polymer that offer a break-resistant, high-performance alternative to glass for complex drugs
- Daikyo RUV components – Ready-to-use, validated components manufactured using clean, high-quality elastomer formulations and then washed, camera-inspected and sterilized to help minimize risks around component preparation and eliminate bioburden
For more information on West products and services, please visit booth #2M22 at CPhI InnoPack Worldwide 2016 or visit us online at www.westpharma.com.
About West
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the worldís pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West’s 2015 sales of $1.4 billion reflect the daily use of approximately 110 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.
